Clinical Research Directory
Browse clinical research sites, groups, and studies.
17 clinical studies listed.
Filters:
Tundra lists 17 Type 2 Diabetes Mellitus (DM) clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07949786
Culturally Based Diabetes Self-Management Education for Adults With Type 2 Diabetes
Type 2 diabetes is a long-term condition that requires patients to manage their diet, physical activity, medication, and blood glucose levels regularly. Diabetes self-management education can help patients improve their knowledge and daily self-care practices. However, educational programs may be more effective when they consider patients' local culture, language, food habits, and family values. This study evaluated the effectiveness of a culturally based Diabetes Self-Management Education (DSME) model among adults with type 2 diabetes in Bone Regency, South Sulawesi, Indonesia. The study involved participants from Puskesmas Cina and used a quasi-experimental design with intervention and control groups. Participants in the intervention group received general counselling supported by a culturally based DSME module developed for the Bugis community. The module covered basic diabetes knowledge, nutrition using locally available foods, physical activity, blood glucose monitoring, foot care, stress management, and family support. The education was delivered in four group sessions, once a week for four consecutive weeks. Participants in the control group received general diabetes counselling without the culturally based module. The study assessed quality of life, diabetes knowledge, self-management practices, and blood glucose levels. Fasting blood glucose and two-hour post-meal blood glucose were monitored over 12 weeks. Quality of life, knowledge, and self-management were assessed before the intervention and at three months. The purpose of this study was to determine whether culturally based diabetes education could improve quality of life, diabetes self-management, and blood glucose control compared with general diabetes counselling.
Gender: All
Ages: 18 Years - 65 Years
Updated: 2026-11-19
1 state
NCT07942480
Intraoral Scanner Assessment of Maxillary Marginal Soft Tissue Volume Change After Non-Surgical Periodontal Therapy in Type 2 Diabetes
Gum treatment (non-surgical periodontal therapy, also called scaling and root planing) reduces swelling in the gums. As the swelling goes down, the gum tissue around the teeth can shrink. This change is hard to measure with routine dental examinations. This study uses a 3D intraoral scanner, which takes digital images of the mouth without X-rays, to measure how much the gum tissue of the upper jaw changes in volume after treatment. The study also asks whether this change is different in people with type 2 diabetes compared with people without diabetes. Diabetes can slow healing and change the body's inflammatory response, but its effect on gum volume after periodontal treatment has not been measured in three dimensions before. Adults with stage III periodontitis who attend the Periodontology clinic at Afyonkarahisar Health Sciences University, Faculty of Dentistry, are invited to take part. Participants receive their routine gum treatment, which is not changed because of the study. Their upper jaw is scanned with an intraoral scanner before treatment and again at the routine 3-month check-up. The two scans are overlaid on a computer, and the change in gum volume is calculated. Researchers then compare people with and without type 2 diabetes. Diabetes status and HbA1c values are taken from existing health records. The study does not require extra blood tests, X-rays, or extra visits.
Gender: All
Ages: 18 Years - Any
Updated: 2026-11-17
NCT07942129
4-7-8 Breathing Exercises for Stress, Well-Being, and Quality of Life in Newly Diagnosed Type 2 Diabetes
This randomized controlled trial aims to evaluate the effects of 4-7-8 breathing exercises on perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus. The study will be conducted at the Internal Medicine Outpatient Clinic of Kayseri City Hospital, Türkiye. A total of 60 patients aged 18-65 years who have been newly diagnosed with type 2 diabetes mellitus and have HbA1c levels of 8% or higher will be enrolled. Participants will be randomly assigned to either the intervention group (n=30) or the control group (n=30) using simple randomization. Participants in the intervention group will perform 4-7-8 breathing exercises twice daily, in the morning and evening, for four weeks, in addition to receiving routine diabetes treatment. The breathing technique involves inhaling through the nose for 4 seconds, holding the breath for 7 seconds, and exhaling through the mouth for 8 seconds. Participants will be instructed to perform four sets per session. Participants in the control group will continue receiving routine diabetes treatment without any additional breathing exercises. Data will be collected at baseline and at the end of the four-week intervention using the Perceived Stress Scale (PSS-14), the World Health Organization-Five Well-Being Index (WHO-5), and the Short Form-36 Health Survey (SF-36). The study will investigate whether 4-7-8 breathing exercises improve perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus compared with routine care alone.
Gender: All
Ages: 18 Years - Any
Updated: 2026-11-17
NCT07939750
Sotagliflozin Versus Empagliflozin Added to Metformin for Glycemic Control in Type 2 Diabetes
The goal of this randomized controlled trial is to compare two medicines added to metformin for blood sugar control in adults with type 2 diabetes whose HbA1c remains between 7.0% and 10.0% despite a stable dose of metformin. The main question it aims to answer is: Does adding sotagliflozin (a dual SGLT1/SGLT2 inhibitor) lower HbA1c more than adding empagliflozin (a selective SGLT2 inhibitor) after 24 weeks? Participants will continue their usual metformin dose and will be randomly assigned to take either sotagliflozin 200 mg or empagliflozin 10 mg once daily for 24 weeks. They will be reviewed at 4, 12 and 24 weeks for adherence, side effects and adverse events, and HbA1c will be measured at baseline and at 24 weeks.
Gender: All
Ages: 30 Years - 65 Years
Updated: 2026-11-16
1 state
NCT07933159
Stress Coping Training for Nurses and Diabetes Control
General Objectives 1. To measure the effectiveness of the stress and coping mechanism training program that is meant to help nurses deal with occupational stress and at the same time provide healthcare services to Type 2 Diabetes Mellitus patients in the Hail Region. 2. To find out the impact of increased ability of nurses to cope with stress and its consequences on blood glucose levels and health of patients with Type 2 Diabetes Mellitus. 3. To explore the connection between nurses' psychological state and quality of the care offered to diabetic patients in the region. 4. To examine the long-term effects of stress management techniques on the performance, emotional state, and engagement of nurses. 5. To explore how training in stress and coping mechanisms could affect the establishment of an empathic environment that would make the patients adhere to diabetes management programs. 6. To provide inputs into the elaboration of integrated healthcare programs that would take into consideration both psychological resilience of nurses and physiological stability of patients with diabetes and other chronic diseases. Specific Objectives 1. To measure occupational stress experienced by the nurses before and after attending a training course on psychological stress and coping methods. 2. To determine the impact of the nurses' training program on patients' glucose control by measuring HbA1c. 3. To determine the relationship between the coping methods used by the nurses and adherence of patients to medications, diet and other self-management practices. 4. To find out the main coping methods used by the nurses which help to reduce stress and promote positive mood while providing nursing care to diabetic patients. 5. To learn patients' perception of the quality of care and communication after attending the nurses' training program on psychological stress and coping mechanisms. 6. To make recommendations about implementing the psychological training and stress management programs into the continuing professional education of nurses working in diabetes care units in Hail Region. Research Questions 1. What is the efficiency of the program aimed at the development of coping and stress training of nurses working with Type 2 Diabetes Mellitus patients in the Hail Region? 2. Is there any effect of improved stress management skills of nurses on the level of glycemic control of their patients, which is measured in terms of HbA1c values? 3. What are the connections between coping mechanisms of nurses and the adherence of their patients to prescribed treatment regimes? 4. What kind of coping strategies help nurses to feel better psychologically and be more satisfied with their job while working with Type 2 Diabetes Mellitus patients? 5. How does the implementation of stress and coping mechanisms training affect patients' perception of the quality of the care provided and communication with nurses? 6. Can psychological training programs have an impact on health care delivery and patient outcomes among Type 2 Diabetes Mellitus patients in the Hail Region?
Gender: All
Ages: 18 Years - Any
Updated: 2026-11-12
1 state
NCT07929233
24-hour Clear Liquid Diet vs. Standard Fasting for Upper Gastrointestinal Endoscopy in Patients Taking Agonists of the GLP-1 Receptor
GLP-1 receptor agonists delay gastric emptying and are associated with a higher rate of retained gastric content (RGC) during upper gastrointestinal endoscopy, even under standard fasting. No randomized trial has compared fasting strategies in this population. CLEAR-GLP1 is a multicentre, international, investigator-blinded randomized trial comparing a 24-hour clear liquid diet (followed by a 2-hour fast) with standard fasting (6 hours for solids, 2 hours for clear liquids) in adults on GLP-1 RA therapy undergoing elective upper endoscopy. GLP-1 RA therapy is not interrupted in either arm. The primary outcome is the rate of clinically significant RGC, defined as a GRACE stomach score of 0.
Gender: All
Ages: 18 Years - Any
Updated: 2026-11-10
NCT07927530
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Patients With Type 2 Diabetes
This prospective, randomized, controlled clinical trial aims to evaluate the efficacy of ultrasound-guided thoracolumbar fascia (TLF) injection as an adjunct to standard conservative treatment in patients with type 2 diabetes mellitus and chronic nonspecific low back pain. A total of 60 patients aged 18-65 years, diagnosed with type 2 diabetes mellitus for at least one year and experiencing chronic nonspecific low back pain for at least three months, will be enrolled. Eligible participants will be randomly assigned to two groups. The intervention group will receive ultrasound-guided thoracolumbar fascia injection in addition to standard conservative treatment, while the control group will receive standard conservative treatment alone, consisting of patient education and a structured exercise program. Clinical assessments will be performed at baseline and at 1 and 3 months after treatment. Treatment outcomes will include pain intensity measured using the Numeric Rating Scale (NRS), functional disability assessed using the Oswestry Disability Index (ODI), pressure pain threshold (PPT) measured by algometry, and analgesic consumption. Thoracolumbar fascia thickness will be measured using ultrasonography at baseline to investigate its potential association with treatment response. Diabetes-related characteristics, including HbA1c levels, diabetes duration, and peripheral neuropathy status, will also be recorded. The primary objective is to determine whether adding ultrasound-guided thoracolumbar fascia injection to standard conservative treatment provides greater improvement in pain intensity and functional disability compared with standard conservative treatment alone. The study will also explore whether baseline thoracolumbar fascia thickness and diabetes-related characteristics are associated with clinical outcomes.
Gender: All
Ages: 18 Years - 65 Years
Updated: 2026-11-10
1 state
NCT07905209
Evaluation of MTHFR and DNMT3B Gene Polymorphisms Along With Periodontal Clinical Parameters in Healthy Individuals and Individuals With Type 2 Diabetes and Periodontitis
Periodontitis is a chronic inflammatory disease that affects the tissues supporting the teeth and can lead to progressive tissue destruction. Type 2 diabetes mellitus is a metabolic disease characterized by persistently elevated blood glucose levels. These two conditions are closely related, and genetic factors may influence their development and severity. This observational study aims to evaluate the distribution of methylenetetrahydrofolate reductase (MTHFR) and DNA methyltransferase 3B (DNMT3B) gene polymorphisms in healthy individuals, individuals with periodontitis, individuals with type 2 diabetes mellitus, and individuals with both conditions. The study also aims to investigate the associations between these genetic variations and periodontal clinical parameters. The study includes 200 participants divided into four groups of 50 individuals each: healthy individuals, individuals with type 2 diabetes without periodontitis, individuals with periodontitis without type 2 diabetes, and individuals with both type 2 diabetes and periodontitis. Periodontal examinations include the assessment of plaque index, gingival index, probing pocket depth, clinical attachment loss, and gingival recession. Venous blood samples are collected for molecular analysis of MTHFR and DNMT3B gene polymorphisms. The findings may contribute to a better understanding of the potential role of genetic factors in periodontal disease and its relationship with type 2 diabetes mellitus.
Gender: All
Ages: 18 Years - Any
Updated: 2026-10-29
1 state
NCT07888426
Tolerability and Safety of Nano-Tocotrienols
The goal of this randomised controlled trial is to determine the long term safety and tolerability of nano-tocotrienols (50 - 400 mg/day for 6-months duration) to be used as a health supplement in both healthy individuals and those with Type 2 diabetes mellitus. The study will compare patients (both healthy and individuals with Type 2 diabetes mellitus) receiving placebo and those receiving nano-tocotrienols. They would then be followed up at 3 months and 6 months intervals to determine if there is any adverse events experienced with the supplement.
Gender: All
Ages: 18 Years - 60 Years
Updated: 2026-10-22
1 state
NCT07872436
A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control
This study will evaluate whether VCT220 tablets improve blood glucose control in adults with type 2 diabetes whose blood glucose remains inadequately controlled with lifestyle intervention alone, metformin alone, or metformin combined with a sodium-glucose cotransporter 2 (SGLT2) inhibitor. The study will also assess safety, tolerability, and how VCT220 is processed by the body. Approximately 120 participants will be randomly assigned in equal proportions to VCT220 40 mg, 80 mg, 120 mg, or placebo, taken orally once daily for 16 weeks. Higher-dose groups will start at 40 mg and increase the dose in steps. Participation will last approximately 22 weeks, including screening, a placebo run-in period, treatment, and safety follow-up. The main assessment is the change in glycated hemoglobin (HbA1c) from baseline to Week 16.
Gender: All
Ages: 18 Years - 65 Years
Updated: 2026-10-13
1 state
NCT07854496
Effect of Otago vs. Sensorimotor Training on Balance and Fall Risk in People With Diabetes
The purpose of this study is to compare the effects of the Otago Exercise Program versus Sensorimotor Training on dynamic postural stability and risk of fall in patients with type 2 diabetes mellitus. Participants will be randomly assigned into two equal intervention groups. One group will receive the Otago Exercise Program, while the other group will receive Sensorimotor Training. Both groups will participate in their respective exercise protocols for 8 weeks. Dynamic postural stability and the risk of falling will be assessed before and after the intervention period using standardized physical therapy evaluation tools.
Gender: All
Ages: 45 Years - 55 Years
Updated: 2026-10-02
NCT07842757
Preoperative Gastric Volume and High-Risk Gastric Content in Patients With Type 2 Diabetes Mellitus
This prospective observational study will evaluate adult patients with type 2 diabetes mellitus who are scheduled for elective surgery. Immediately before preoperative gastric ultrasonography, capillary fasting blood glucose will be measured. Gastric contents will be assessed qualitatively in the supine and right lateral decubitus positions, and residual gastric volume will be estimated using the antral cross-sectional area measured in the right lateral decubitus position. The primary objective is to evaluate the association between fasting capillary blood glucose and the presence of a high-risk stomach. A high-risk stomach will be defined as the presence of solid gastric contents, Perlas Grade 2 gastric contents, or an estimated gastric volume greater than 1.5 mL/kg. Secondary objectives include determining the prevalence of a high-risk stomach and evaluating its associations with demographic characteristics, diabetes-related factors, comorbidities, fasting duration, medication use, gastroparesis-related symptoms, and routine laboratory parameters.
Gender: All
Ages: 18 Years - Any
Updated: 2026-09-30
1 state
NCT07832656
Proteome-Wide Association and LLM-Based Prioritization of Type 2 Diabetes Protein Targets
Type 2 diabetes is a common condition in which the body has difficulty controlling blood sugar. This study will use existing genetic, protein, and health data from prior research studies to identify blood proteins that may play a role in type 2 diabetes. The study will not recruit participants, provide treatment, or collect new samples. Researchers will use computer-based analyses to identify and prioritize protein targets for future laboratory and clinical research. The goal is to support the development of better approaches for understanding, preventing, and treating type 2 diabetes.
Gender: All
Ages: 40 Years - 84 Years
Updated: 2026-09-28
NCT06787859
Nature Image Exposure in Type 2 Diabetes
Type 2 diabetes often requires repeated procedures, including insulin self-injection and self-monitoring of blood glucose. These procedures may cause pain and lead to fear of self-injection and blood glucose testing, which may negatively affect treatment adherence and diabetes self-management. Nature-based visual stimuli may serve as a simple, non-pharmacological distraction method by directing attention away from painful or fear-inducing procedures. This randomized controlled trial evaluated the effects of nature image exposure on pain, fear of self-injection, and fear of blood glucose testing in adults with type 2 diabetes. A total of 64 participants were randomly assigned to either the intervention group (n=32) or the control group (n=32). Participants in the intervention group viewed a standardized nature image displayed on a fixed wall-mounted screen for 3-5 minutes immediately before insulin self-injection and self-monitoring of blood glucose. Participants in the control group received standard care without nature image exposure. Outcomes were assessed using the Diabetes Fear of Injecting and Self-Testing Questionnaire and the Visual Analog Scale.
Gender: All
Ages: 18 Years - Any
Updated: 2026-09-21
1 state
NCT07830537
Preoperative Oral Carbohydrate Loading in Patients With Type 2 Diabetes Undergoing Gastrointestinal Surgery
This study is a single-center randomized controlled trial in adults with type 2 diabetes who are scheduled for elective gastrointestinal surgery. The study aims to find out whether drinking a carbohydrate-containing clear liquid before surgery can reduce early postoperative insulin resistance and improve blood glucose stability without increasing the risk of high or low blood glucose. Participants will be randomly assigned in a 1:1:1 ratio to one of three groups. The first group will receive standard enhanced recovery after surgery (ERAS) fasting and clear-fluid management without a carbohydrate-containing drink. The second group will drink 400 mL of a 12.5% maltodextrin carbohydrate solution, providing about 50 g of carbohydrate, approximately 2 hours before anesthesia. The third group will receive 500 mL of 10% glucose solution intravenously over approximately 2 hours before anesthesia. The intravenous glucose group is included mainly to help explore whether the route of carbohydrate administration affects the metabolic response. All participants will receive standard perioperative care. Blood glucose will be monitored during the perioperative period, including continuous glucose monitoring when available, with point-of-care blood glucose testing used to confirm clinically important high or low glucose readings and to guide treatment when necessary. The primary outcome is insulin resistance on the first day after surgery, measured using the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), which is calculated from fasting blood glucose and fasting insulin concentrations. Secondary outcomes include perioperative glucose levels and glucose variability, time spent within, above, and below the target glucose range, insulin and C-peptide levels, postoperative nausea and vomiting, patient comfort, postoperative recovery, hospital stay, postoperative complications, and safety events such as hypoglycemia, severe hyperglycemia, reflux, or aspiration. The main comparison of interest is between the oral carbohydrate group and the standard ERAS group. The intravenous glucose group will be analyzed mainly as a mechanistic exploratory group.
Gender: All
Ages: 18 Years - 75 Years
Updated: 2026-09-21
NCT07827625
Mulligan Mobilization With Movement Versus Conventional Physiotherapy on Ankle Range of Motion, Mobility, Pain, and Quality of Life in Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (T2DM) is a major global health concern associated with chronic hyperglycemia, oxidative stress, and accumulation of advanced glycation end-products, which impair connective tissue function and commonly restrict ankle (tibiotalar) mobility. Reduced ankle range of motion, neuropathic pain, and gait instability significantly impair daily activities and quality of life in this population, and reduced ankle mobility is further associated with increased risk of diabetic foot ulceration. Conventional physiotherapy is widely used to address these impairments through exercise, stretching, and strengthening, but may not fully resolve mechanical joint restrictions. Mulligan's Mobilization with Movement (MWM) is a manual therapy technique in which a sustained glide is applied to the ankle during active weight-bearing movement, correcting positional faults and improving dorsiflexion range of motion. While MWM has shown benefit in non-diabetic ankle conditions, its effectiveness relative to conventional physiotherapy in patients with T2DM remains unclear. This study is a randomized controlled trial comparing the effects of Mulligan Mobilization with Movement (Group A) versus conventional physiotherapy (Group B) on pain intensity, ankle range of motion, functional mobility, and quality of life in adults aged 50-70 years with Type 2 Diabetes Mellitus of more than 5 years' duration. A total of 56 participants will be recruited using non-probability purposive sampling and randomly allocated by coin-toss method into two equal groups of 28. Both groups will receive baseline treatment (hot pack application and gentle active ankle movement) followed by their assigned protocol - Group A receiving MWM (sustained anteroposterior/posteroanterior glide to the distal tibia or fibula during active dorsiflexion or plantarflexion, 3 sets of 10 repetitions) and Group B receiving conventional physiotherapy (active/passive range-of-motion exercises, calf raises, and calf/Achilles stretching) - three sessions per week for six weeks. Outcomes will be assessed at baseline and following the six-week intervention period. Primary outcome measures include pain intensity (Numeric Pain Rating Scale), ankle range of motion (goniometer), functional mobility (Timed Up and Go test), and quality of life (SF-12 Health Survey). Data will be analyzed using IBM SPSS Statistics version 27, with normality assessed via the Shapiro-Wilk test and within- and between-group comparisons made using parametric or non-parametric tests as appropriate. This trial is expected to generate direct comparative evidence on whether Mulligan Mobilization with Movement offers superior outcomes to conventional physiotherapy for ankle-related impairments in patients with T2DM, helping physiotherapists select more targeted, evidence-based rehabilitation protocols for this population.
Gender: All
Ages: 50 Years - 70 Years
Updated: 2026-09-18
1 state
NCT05743387
Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho
This cluster-randomized intervention is embedded in the ComBaCaL (Community-Based Chronic disease care Lesotho) cohort study (EKNZ ID AO\_2022-00058, clinicaltrials.gov ID NCT05596773, Lesotho NH-REC ID 210-2022), a platform for the investigation of chronic diseases and their management in rural Lesotho that is maintained by local lay village health workers (VHWs). The overall objective of the ComBaCaL cohort study and nested TwiCs is to assess the impact of eHealthsupported, lay-led chronic disease control measures in rural Lesotho. In this DM TwiC, the effect, safety and feasibility of a community-based DM care package (which includes the offer of first-line oral antidiabetic and lipid-lowering treatment for uncomplicated DM by lay VHWs in comparison to facility-based care after community-based screening and diagnosis) will be evaluated.
Gender: All
Ages: 18 Years - Any
Updated: 2026-09-10